ES547931A0 - Procedimiento para la obtencion de un medicamento que con contiene como sustencia activa la combinacion de dihidropiridinas con inhibidores ace - Google Patents

Procedimiento para la obtencion de un medicamento que con contiene como sustencia activa la combinacion de dihidropiridinas con inhibidores ace

Info

Publication number
ES547931A0
ES547931A0 ES547931A ES547931A ES547931A0 ES 547931 A0 ES547931 A0 ES 547931A0 ES 547931 A ES547931 A ES 547931A ES 547931 A ES547931 A ES 547931A ES 547931 A0 ES547931 A0 ES 547931A0
Authority
ES
Spain
Prior art keywords
combination
dihydropyridine
procedure
obtaining
active substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES547931A
Other languages
English (en)
Other versions
ES8703089A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6248017&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES547931(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer AG filed Critical Bayer AG
Publication of ES547931A0 publication Critical patent/ES547931A0/es
Publication of ES8703089A1 publication Critical patent/ES8703089A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
ES547931A 1984-10-17 1985-10-16 Procedimiento para la obtencion de un medicamento que con contiene como sustencia activa la combinacion de dihidropiridinas con inhibidores ace Expired ES8703089A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843437917 DE3437917A1 (de) 1984-10-17 1984-10-17 Kombination von dihydropyridinen mit ace-hemmern sowie ihre verwendung in arzneimitteln

Publications (2)

Publication Number Publication Date
ES547931A0 true ES547931A0 (es) 1987-02-01
ES8703089A1 ES8703089A1 (es) 1987-02-01

Family

ID=6248017

Family Applications (1)

Application Number Title Priority Date Filing Date
ES547931A Expired ES8703089A1 (es) 1984-10-17 1985-10-16 Procedimiento para la obtencion de un medicamento que con contiene como sustencia activa la combinacion de dihidropiridinas con inhibidores ace

Country Status (16)

Country Link
US (1) US4703038A (es)
EP (1) EP0180785B1 (es)
JP (1) JPS6197228A (es)
KR (1) KR860003020A (es)
AT (1) ATE44650T1 (es)
AU (1) AU4840085A (es)
CA (1) CA1251733A (es)
DD (1) DD239525A5 (es)
DE (2) DE3437917A1 (es)
DK (1) DK473585A (es)
ES (1) ES8703089A1 (es)
GR (1) GR852493B (es)
HU (1) HU194053B (es)
IL (1) IL76697A0 (es)
PT (1) PT81308B (es)
ZA (1) ZA857932B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3542794A1 (de) * 1985-12-04 1987-06-11 Bayer Ag Antihypertensives kombinationspraeparat
DE3629060A1 (de) * 1986-08-27 1988-03-03 Bayer Ag Kombination von positiv inotrop wirkenden dihydropyridinen mit ace-hemmern, sowie ihre verwendung in arzneimitteln
EP0259838A3 (en) * 1986-09-09 1989-11-15 Syntex (U.S.A.) Inc. Pharmaceutical composition containing a 1,4-dihydropyridine derivative and an acylated 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid
DE3633496A1 (de) * 1986-10-02 1988-04-14 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit calciumantagonisten sowie deren verwendung in arzneimitteln
DE3636123A1 (de) * 1986-10-23 1988-05-05 Rentschler Arzneimittel Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten
HU199681B (en) * 1986-11-03 1990-03-28 Sandoz Ag Process for producing new pharmaceutical composition against hypertension and atonic cardiac decomposition
USH734H (en) * 1988-03-07 1990-02-06 E. R. Squibb & Sons, Inc. Method for inhibiting onset of or treating migraine headaches employing an ACE inhibitor
JPH01275529A (ja) * 1988-03-21 1989-11-06 E R Squibb & Sons Inc 晩発性運動障害の抑制治療剤
DE3818245A1 (de) * 1988-05-28 1989-12-07 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit kaliumkanal-modulatoren sowie deren verwendung in arzneimitteln
JP2919607B2 (ja) * 1989-03-22 1999-07-12 ピーター ケー テイー パング パラシロイド高血圧性因子
US5350771A (en) * 1989-03-22 1994-09-27 Peter K. T. Pang Method and treatment for hypertension using combination therapy involving exogenous calcium and calcium channel blockers
US5886012A (en) * 1989-03-22 1999-03-23 Peter K. T. Pang Method of treatment for disease associated with excessive PHF using combination therapy involving exogenous calcium and calcium channel blockers
TW197945B (es) * 1990-11-27 1993-01-11 Hoechst Ag
ATE180972T1 (de) * 1990-12-17 1999-06-15 Gosbert Dr Med Dr Rer Nat Weth Verwendung von n-(aminoacyl)-aminosäuren zur herstellung von dopaminergen und gonadotropen arzneimitteln.
US6162802A (en) * 1992-03-10 2000-12-19 Papa; Joseph Synergistic combination therapy using benazepril and amlodipine for the treatment of cardiovascular disorders and compositions therefor
TW483763B (en) * 1994-09-02 2002-04-21 Astra Ab Pharmaceutical composition comprising of ramipril and dihydropyridine compound
ES2125198B1 (es) * 1997-05-13 1999-11-16 Vita Invest Sa Asociacion a dosis fija de un inhibidor de la enzima convertidora de angiotensina y de un antagonista de los canales de calcio, procedimiento para su preparacion y su utilizacion para el tratamiento de enfermees cardiovasculares.
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
US6569456B2 (en) 2000-01-13 2003-05-27 Osmotica Corp. Osmotic device containing diltiazem and an ACE inhibitor or diuretic
GB0113839D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
GB0318094D0 (en) * 2003-08-01 2003-09-03 Pfizer Ltd Novel combination
US20050032879A1 (en) * 2003-08-07 2005-02-10 Temple Okarter Formulations and use of a beta-blocker and an ACE-inhibitor for the treatment of cardiovascular diseases
WO2005037317A2 (en) * 2003-10-17 2005-04-28 Cornell Research Foundation, Inc. Mast cell-derived renin
US10517839B2 (en) * 2008-06-09 2019-12-31 Cornell University Mast cell inhibition in diseases of the retina and vitreous

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3966948A (en) * 1970-01-24 1976-06-29 Bayer Aktiengesellschaft Spasmolytic, vaso-dilating and anti-hypertensive compositions and methods
US3971791A (en) * 1972-03-06 1976-07-27 Bayer Aktiengesellschaft 2-Amino-1,4-dihydropyridine derivatives
US3966946A (en) * 1973-06-12 1976-06-29 Smith Kline & French Laboratories Limited 1,4-Dihydropyridine compounds in treating hypertension
IL58849A (en) * 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
US4703038A (en) 1987-10-27
DE3437917A1 (de) 1986-04-17
JPS6197228A (ja) 1986-05-15
GR852493B (es) 1986-02-11
CA1251733A (en) 1989-03-28
AU4840085A (en) 1986-04-24
DK473585D0 (da) 1985-10-16
KR860003020A (ko) 1986-05-19
DD239525A5 (de) 1986-10-01
EP0180785A1 (de) 1986-05-14
PT81308A (en) 1985-11-01
HUT40331A (en) 1986-12-28
EP0180785B1 (de) 1989-07-19
ZA857932B (en) 1986-05-28
DE3571550D1 (en) 1989-08-24
ES8703089A1 (es) 1987-02-01
DK473585A (da) 1986-04-18
HU194053B (en) 1988-01-28
ATE44650T1 (de) 1989-08-15
IL76697A0 (en) 1986-02-28
PT81308B (en) 1987-08-05

Similar Documents

Publication Publication Date Title
ES547931A0 (es) Procedimiento para la obtencion de un medicamento que con contiene como sustencia activa la combinacion de dihidropiridinas con inhibidores ace
ES547738A0 (es) Un procedimiento para la preparacion de una composicion terapeutica que contiene un fosfato de dialquilo.
NO860371L (no) Fremgangsmaate ved fremstilling av peptidaseinhibitorer.
NO853046L (no) Fremgangsmaate for fremstilling av terapeutisk aktive indol-derivater.
NO159089C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive glutarimidderivater.
NO882218L (no) Fremgangsmaate for fremstilling av fosforholdige hmg-coa reduktase-inhibitorer.
NO167142C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater.
NO162115C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5h-2,3-benzodiazepinderivater.
ES529593A0 (es) Procedimiento para preparar nuevos derivados de benzazocinona y de benzazoninona
NO164097C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-(n-substituert-guanidino)-4-hetero-aryl-tiazol-derivater.
NO864879L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser.
MX162676A (es) Procedimiento para la preparacion de derivados de 2-(piridilalquensulfinii.)benzimidazoles n-substituidos
NO882219L (no) Fremgangsmaate for fremstilling av fosforholdige hmg-coa reduktase-inhibitorer.
NO165400C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cefemforbindelser.
ES540379A0 (es) Un procedimiento para la preparacion de una composicion de amidas de acidos carboxilicos y de acidos fosforicos organicos.
NO164897C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater.
NO165842C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-forbindelser.
NO164295C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive fluorerte benzyltriazolforbindelser.
NO167570C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive flavonforbindelser.
NO161313C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater.
ES541436A0 (es) Procedimiento para preparar un agente farmaceutico que con- tiene un inhibidor de la enzima convertidora de angiotensina
ES556437A0 (es) Procedimiento para preparar un agente que contiene tirosina o un derivado de tirosina como sustancia activa para mejorar la fecundidad de mamiferos.
NO161064C (no) Analogifremgangsmaate til fremstilling av fenyl-nonatetraensyrederivater.
GR3032175T3 (en) IMPROVED SYSTEM FOR THE TRANSDERMAL APPLICATION OF PHARMACOLOGICALLY ACTIVE COMPOUNDS AT CONTROLLED pH.
NO162820C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrazolpyridin- eller benzimidazolderivater.